ATE92935T1 - Serinproteaseinhibitoren und isolierungsverfahren dazu. - Google Patents
Serinproteaseinhibitoren und isolierungsverfahren dazu.Info
- Publication number
- ATE92935T1 ATE92935T1 AT86900423T AT86900423T ATE92935T1 AT E92935 T1 ATE92935 T1 AT E92935T1 AT 86900423 T AT86900423 T AT 86900423T AT 86900423 T AT86900423 T AT 86900423T AT E92935 T1 ATE92935 T1 AT E92935T1
- Authority
- AT
- Austria
- Prior art keywords
- serine protease
- protease inhibitor
- inhibitor
- ability
- inhibit
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 238000002955 isolation Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N serine Chemical compound OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 title 2
- 241000208465 Proteaceae Species 0.000 title 1
- 241001522306 Serinus serinus Species 0.000 title 1
- 235000019419 proteases Nutrition 0.000 title 1
- 101710102218 Serine protease inhibitor Proteins 0.000 abstract 6
- 239000003001 serine protease inhibitor Substances 0.000 abstract 6
- 229940122055 Serine protease inhibitor Drugs 0.000 abstract 5
- 238000004925 denaturation Methods 0.000 abstract 2
- 230000036425 denaturation Effects 0.000 abstract 2
- LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 abstract 1
- 102000004173 Cathepsin G Human genes 0.000 abstract 1
- 108090000617 Cathepsin G Proteins 0.000 abstract 1
- 102000016387 Pancreatic elastase Human genes 0.000 abstract 1
- 108010067372 Pancreatic elastase Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 102000004142 Trypsin Human genes 0.000 abstract 1
- 108090000631 Trypsin Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 239000012588 trypsin Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Detergent Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67882384A | 1984-12-06 | 1984-12-06 | |
| US80347185A | 1985-12-02 | 1985-12-02 | |
| EP86900423A EP0205555B2 (de) | 1984-12-06 | 1985-12-04 | Serinproteaseinhibitoren und isolierungsverfahren dazu |
| PCT/US1985/002384 WO1986003497A1 (en) | 1984-12-06 | 1985-12-04 | Serine protease inhibitors and methods for isolation of same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE92935T1 true ATE92935T1 (de) | 1993-08-15 |
Family
ID=27102098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86900423T ATE92935T1 (de) | 1984-12-06 | 1985-12-04 | Serinproteaseinhibitoren und isolierungsverfahren dazu. |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0205555B2 (de) |
| AT (1) | ATE92935T1 (de) |
| AU (1) | AU591474B2 (de) |
| DE (1) | DE3587526T3 (de) |
| WO (1) | WO1986003497A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6291662B1 (en) | 1984-12-05 | 2001-09-18 | Amgen Inc. | Recombinant methods for production of serine protease inhibitors and DNA sequences |
| US5871956A (en) * | 1984-12-06 | 1999-02-16 | Amgen Inc. | Recombinant methods for production of serine inhibitors and DNA sequences useful for same |
| US6132990A (en) * | 1984-12-06 | 2000-10-17 | Amgen Boulder Inc. | Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same |
| US5900400A (en) * | 1984-12-06 | 1999-05-04 | Amgen Inc. | Serine protease inhibitor analogs |
| DE3600571A1 (de) * | 1986-01-10 | 1987-08-06 | Gruenenthal Gmbh | Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel |
| EP0238473A3 (de) * | 1986-03-18 | 1989-06-07 | Monsanto Company | Serinprotease-Hemmungsstoffe |
| DE3841873A1 (de) * | 1988-12-13 | 1990-06-21 | Gruenenthal Gmbh | Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen |
| JPH0739329B2 (ja) * | 1989-03-13 | 1995-05-01 | 味の素株式会社 | 植物の開花を制御する方法及び植物の開花制御剤 |
| FR2647677B1 (fr) * | 1989-05-31 | 1991-09-27 | Roussel Uclaf | Nouvelles micro-proteines, procede de preparation et application a titre de medicaments de ces nouvelles micro-proteines |
| DE69129747T2 (de) * | 1990-09-05 | 1998-11-12 | Southern Cross Biotech Pty. Ltd., Toorak, Victoria | In lösung bringen von proteinen in aktiver form |
| US6869925B1 (en) * | 1992-09-09 | 2005-03-22 | Amgen Inc. | Inhibition of retrovirus infection |
| US6017880A (en) * | 1994-03-09 | 2000-01-25 | Amgen Inc. | Inhibition of retrovirus infection |
| PL316444A1 (en) * | 1994-03-23 | 1997-01-20 | Tokyo Tanabe Co | Novel agent against viral diseases of respiratory tracts |
| US5633227A (en) * | 1994-09-12 | 1997-05-27 | Miles, Inc. | Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| EP0834556A1 (de) * | 1996-09-25 | 1998-04-08 | Academisch Ziekenhuis Leiden | Verfahren zur Zellkultivierung |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE668563A (de) * | 1964-09-22 | 1965-12-16 | ||
| AU577259B2 (en) * | 1982-08-13 | 1988-09-22 | Zymogenetics Inc. | Glycolytic promters for regulated protein expression protease inhibitor |
| AU560584B2 (en) * | 1983-07-28 | 1987-04-09 | Bayer Aktiengesellschaft | Homologues of aprotinin |
| JPS60186290A (ja) * | 1983-08-10 | 1985-09-21 | チモ−ジエネテイツクス インコ−ポレ−テツド | アルフア−1−アンチトリプシンを細菌に表現させる方法 |
| US4711848A (en) * | 1984-03-14 | 1987-12-08 | Zymogenetics, Inc. | Site specific mutagenesis in alpha-1-antitrypsin |
| AU590238B2 (en) * | 1984-12-06 | 1989-11-02 | Amgen, Inc. | Recombinant methods for production of serine protease inhibitors and dna sequences useful for same |
-
1985
- 1985-12-04 DE DE3587526T patent/DE3587526T3/de not_active Expired - Lifetime
- 1985-12-04 AU AU52328/86A patent/AU591474B2/en not_active Expired
- 1985-12-04 WO PCT/US1985/002384 patent/WO1986003497A1/en not_active Ceased
- 1985-12-04 AT AT86900423T patent/ATE92935T1/de not_active IP Right Cessation
- 1985-12-04 EP EP86900423A patent/EP0205555B2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0205555B1 (de) | 1993-08-11 |
| WO1986003497A1 (en) | 1986-06-19 |
| DE3587526T2 (de) | 1993-11-25 |
| DE3587526D1 (de) | 1993-09-16 |
| EP0205555A4 (de) | 1987-11-09 |
| EP0205555A1 (de) | 1986-12-30 |
| AU591474B2 (en) | 1989-12-07 |
| EP0205555B2 (de) | 2002-04-10 |
| AU5232886A (en) | 1986-07-01 |
| DE3587526T3 (de) | 2002-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK374286A (da) | Serinproteaseinhibitorer og fremgangsmaade til isolering af disse | |
| Gutiérrez et al. | Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo) | |
| ATE92935T1 (de) | Serinproteaseinhibitoren und isolierungsverfahren dazu. | |
| Bernardes et al. | Isolation and structural characterization of a new fibrin (ogen) olytic metalloproteinase from Bothrops moojeni snake venom | |
| PT94016A (pt) | Processo para a producao de inibidores de proteinases | |
| CO4600683A1 (es) | Bikunina humana | |
| ATE74379T1 (de) | Peptidplasminogenaktivatoren. | |
| ATE97421T1 (de) | Gentechnologisch hergestellter pankreatischer sekretorischer trypsininhibitor und seine varianten. | |
| Jagadeesha et al. | A non-toxic anticoagulant metalloprotease: purification and characterization from Indian cobra (Naja naja naja) venom | |
| Laraba-Djebari et al. | A fibrinogen-clotting serine proteinase from Cerastes cerastes (horned viper) venom with arginine-esterase and amidase activities. Purification, characterization and kinetic parameter determination | |
| ATE507289T1 (de) | Ein plasmaprotein-fragment erzeugendes enzym mit krebsmetastase-hemmender wirkung und durch dieses enzym fragmentiertes plasmaprotein-fragment | |
| IL122305A0 (en) | Tace polypeptide its production and its use | |
| Zaganelli et al. | Purification and characterization of a fibrinogen-clotting enzyme from the venom of jararacuçu (Bothrops jararacussu) | |
| DK0458937T3 (da) | Varianter af PAI-2 | |
| EA199700241A1 (ru) | Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран | |
| de Araújo et al. | Purification from Bothrops lanceolatus (fer de lance) venom of a fibrino (geno) lytic enzyme with esterolytic activity | |
| Marsh | Inventory of haemorrhagic factors from snake venoms | |
| Pirkle et al. | Catroxobin, a weakly thrombin-like enzyme from the venom of Crotalus atrox. NH2-terminal and active site amino acid sequences | |
| Kerfelec et al. | The inactive subunit of ruminant procarboxypeptidase A‐S6 complexes: Structural basis of inactivity and physiological role | |
| Terada et al. | Purification and amino acid sequence of brevilysin L6, a non-hemorrhagic metalloprotease from Agkistrodon halys brevicaudus venom | |
| ATE109796T1 (de) | Gewebeinhibitor für metalloproteasen (timp-2). | |
| Mähar et al. | Purification and properties of a proteinase from Vipera lebetina (snake) venom | |
| Kruzel et al. | Separation of Crotalus atrox (Western diamondback rattlesnake) α-proteinase from serine proteinase and hemorrhagic factor activities | |
| RU95109909A (ru) | Способ ингибирования ретровирусной инфекции, ингибитор протеазы, кодирующая его нуклеиновая кислота и способ рекомбинантного продуцирования серинового ингибитора | |
| Wize et al. | Activation of human leucocyte procollagenase by rheumatoid synovial tissue culture medium. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner | ||
| EEIH | Change in the person of patent owner | ||
| UEP | Publication of translation of european patent specification |
Ref document number: 0205555 Country of ref document: EP |
|
| EELA | Cancelled due to lapse of time |